依达拉奉注射液治疗急性脑梗死的疗效观察

Efficacy of Yidalafeng Injection in Treatment of Acute Ischemic Stroke

目的与常规治疗药物对比,观察加用自由基清除剂依达拉奉注射液治疗急性脑梗死的临床效果。方法选择病程在48h内的急性脑梗死80例,随机分为治疗组和对照组各40例,在常规应用活血化淤、保护脑细胞、营养神经和对症等治疗的基础上,治疗组加用依达拉奉30mg,静脉滴注,每天2次,共用14d。第14天后两组治疗方案相同。在治疗2周后进行疗效评定。结果14d后治疗组和对照组有显著性差异(P<0.01)。结论依达拉奉治疗急性脑梗死安全有效。

Objective To investigate the efficacy of Yidalafeng injection in treatment of acute iscbemic stroke. Methods Eighty patients with acute iscbemic stroke were randomly divided into two groups, Yidalafeng group and control group,which were given Yidalafeng injection or routine therapy respectively. Nerve function deficit score was observed to evaluate the efficacy of drugs. Results The effective rate in Yidalafeng group was 77.5% while that was 57.5% in control group. There was significantly different between two groups （P〈 0.01 ）. Conclusion Yidalafeng is effective in treatment of acute ischemic stroke.